The value of obinutuzumab for untreated advanced Follicular Lymphoma: an assessment based on Multicriteria Decision Analysis (MCDA)
Introduction: Multicriteria Decision Analysis (MCDA) provides a framework that enhances transparency and repeatability of decisions taken on a multicriteria basis. Objective: This analysis aims at assessing obinutuzumab compared to rituximab used as a first-line treatment for Follicular Lymphoma...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AboutScience Srl
2019-11-01
|
| シリーズ: | AboutOpen |
| 主題: | |
| オンライン･アクセス: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/302 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|